📣 VC round data is live. Check it out!

Jiangsu Yuyue Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Jiangsu Yuyue Medical and similar public comparables like Ottobock, LivaNova, Envista Holdings, Merit Medical Systems and more.

Jiangsu Yuyue Medical Overview

About Jiangsu Yuyue Medical

Jiangsu Yuyue Medical Equipment And Supply Co Ltd is engaged in providing household medical devices, medical clinical products, and related medical services, R&D, manufacturing and sales of medical device products, and providing related solutions. The company's products are mainly focused on respiratory oxygen production, diabetes care, infection control solutions, household electronic testing and in vitro diagnostics, first aid, and clinical and rehabilitation devices.


Founded

2007

HQ

China

Employees

6.3K

Website

yuwell.com

Financials (LTM)

Revenue: $1B
EBITDA: $238M

EV

$4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Jiangsu Yuyue Medical Financials

Jiangsu Yuyue Medical reported last 12-month revenue of $1B and EBITDA of $238M.

In the same LTM period, Jiangsu Yuyue Medical generated $615M in gross profit, $238M in EBITDA, and $225M in net income.

Revenue (LTM)


Jiangsu Yuyue Medical P&L

In the most recent fiscal year, Jiangsu Yuyue Medical reported revenue of $1B and EBITDA of $289M.

Jiangsu Yuyue Medical is profitable as of last fiscal year, with gross margin of 51%, EBITDA margin of 25%, and net margin of 19%.

See analyst estimates for Jiangsu Yuyue Medical
LTMLast FY202320242025202620272028
Revenue$1B$1B$1B$1B$1B
Gross Profit$615M$595M$607M$561M$595M
Gross Margin51%51%51%50%51%
EBITDA$238M$289M$464M$326M$289M
EBITDA Margin20%25%39%29%25%
EBIT Margin20%20%27%23%19%
Net Profit$225M$219M$354M$267M$219M
Net Margin19%19%30%24%19%

Financial data powered by Morningstar, Inc.

Jiangsu Yuyue Medical Stock Performance

Jiangsu Yuyue Medical has current market cap of $4B, and enterprise value of $4B.

Market Cap Evolution


Jiangsu Yuyue Medical's stock price is $3.97.

Jiangsu Yuyue Medical share price increased by 1.8% in the last 30 days, and decreased by 23.3% in the last year.

Jiangsu Yuyue Medical has an EPS (earnings per share) of $0.22.

See more trading valuation data for Jiangsu Yuyue Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$4B0.9%1.8%-20.2%-23.3%$0.22

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Jiangsu Yuyue Medical Valuation Multiples

Jiangsu Yuyue Medical trades at 3.2x EV/Revenue multiple, and 16.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Jiangsu Yuyue Medical

EV / Revenue (LTM)


Jiangsu Yuyue Medical Financial Valuation Multiples

As of June 3, 2026, Jiangsu Yuyue Medical has market cap of $4B and EV of $4B.

Jiangsu Yuyue Medical has a P/E ratio of 17.7x.

LTMLast FY202320242025202620272028
EV/Revenue3.2x3.3x3.3x3.4x3.3x
EV/EBITDA16.2x13.3x8.3x11.8x13.3x
EV/EBIT15.6x16.3x12.2x15.0x17.3x
EV/Gross Profit6.2x6.5x6.3x6.9x6.5x
P/E17.7x18.2x11.2x14.9x18.2x
EV/FCF-18.9x13.0x15.4x18.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Jiangsu Yuyue Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Jiangsu Yuyue Medical Margins & Growth Rates

Jiangsu Yuyue Medical grew revenue by 9% but EBITDA decreased by 8% in the last fiscal year.

In the most recent fiscal year, Jiangsu Yuyue Medical reported gross margin of 51%, EBITDA margin of 25%, and net margin of 19%.

See estimated margins and future growth rates for Jiangsu Yuyue Medical

Jiangsu Yuyue Medical Margins

Last FY202420252026202720282029
Gross Margin51%50%51%51%
EBITDA Margin25%29%25%21%
EBIT Margin20%23%19%20%
Net Margin19%24%19%18%
FCF Margin17%22%17%-

Jiangsu Yuyue Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth9%(5%)5%9%
Gross Profit Growth9%(8%)6%9%
EBITDA Growth(8%)(30%)(11%)(8%)
EBIT Growth10%(18%)(14%)17%
Net Profit Growth8%(25%)(18%)8%
FCF Growth-(15%)(19%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Jiangsu Yuyue Medical Operational KPIs

Jiangsu Yuyue Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Jiangsu Yuyue Medical's Rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Jiangsu Yuyue Medical's Rule of X is 43% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Jiangsu Yuyue Medical
LTMLast FY202320242025202620272028
Rule of 4030%30%---
Bessemer Rule of X46%43%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue21%22%9%13%16%
G&A Expenses to Revenue7%7%1%2%2%
R&D Expenses to Revenue7%7%6%7%7%
Opex to Revenue-32%25%27%32%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Jiangsu Yuyue Medical Competitors

Jiangsu Yuyue Medical competitors include Ottobock, LivaNova, Envista Holdings, Merit Medical Systems, BillionToOne, APT Medical, Mirion, iRhythm Holdings, Medacta Group and Minimed Group.

Most Jiangsu Yuyue Medical public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Ottobock2.8x2.7x15.2x10.6x
LivaNova2.8x2.7x12.1x11.6x
Envista Holdings1.6x1.5x11.4x11.0x
Merit Medical Systems2.6x2.5x10.4x10.2x
BillionToOne12.9x10.7x105.5x67.9x
APT Medical10.9x9.9x26.8x25.0x
Mirion5.7x5.2x23.0x20.6x
iRhythm Holdings4.9x4.5x52.9x42.3x

This data is available for Pro users. Sign up to see all Jiangsu Yuyue Medical competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Jiangsu Yuyue Medical

When was Jiangsu Yuyue Medical founded?Jiangsu Yuyue Medical was founded in 2007.
Where is Jiangsu Yuyue Medical headquartered?Jiangsu Yuyue Medical is headquartered in China.
How many employees does Jiangsu Yuyue Medical have?As of today, Jiangsu Yuyue Medical has over 6K employees.
Is Jiangsu Yuyue Medical publicly listed?Yes, Jiangsu Yuyue Medical is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of Jiangsu Yuyue Medical?Jiangsu Yuyue Medical trades under 002223 ticker.
When did Jiangsu Yuyue Medical go public?Jiangsu Yuyue Medical went public in 2008.
Who are competitors of Jiangsu Yuyue Medical?Jiangsu Yuyue Medical main competitors include Ottobock, LivaNova, Envista Holdings, Merit Medical Systems, BillionToOne, APT Medical, Mirion, iRhythm Holdings, Medacta Group, Minimed Group.
What is the current market cap of Jiangsu Yuyue Medical?Jiangsu Yuyue Medical's current market cap is $4B.
What is the current revenue of Jiangsu Yuyue Medical?Jiangsu Yuyue Medical's last 12 months revenue is $1B.
What is the current revenue growth of Jiangsu Yuyue Medical?Jiangsu Yuyue Medical revenue growth (NTM/LTM) is 11%.
What is the current EV/Revenue multiple of Jiangsu Yuyue Medical?Current revenue multiple of Jiangsu Yuyue Medical is 3.2x.
What is the current EBITDA of Jiangsu Yuyue Medical?Jiangsu Yuyue Medical's last 12 months EBITDA is $238M.
What is Jiangsu Yuyue Medical's EBITDA margin?Jiangsu Yuyue Medical's last 12 months EBITDA margin is 20%.
What is the current EV/EBITDA multiple of Jiangsu Yuyue Medical?Current EBITDA multiple of Jiangsu Yuyue Medical is 16.2x.
How many companies Jiangsu Yuyue Medical has acquired to date?Jiangsu Yuyue Medical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Jiangsu Yuyue Medical has invested to date?Jiangsu Yuyue Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Jiangsu Yuyue Medical

Lists including Jiangsu Yuyue Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial